Healthy Subject Clinical Trial
Official title:
An Exploratory Approach for Validation and Standardization of Test Methods and Evaluators to Conduct In-Vivo Clinical Safety and Efficacy Testing of Hair Care Range of Products
NCT number | NCT05763888 |
Other study ID # | NB220039-NB |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | April 12, 2023 |
Est. completion date | May 1, 2023 |
Verified date | May 2023 |
Source | NovoBliss Research Pvt Ltd |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
An exploratory approach for validation and standardization of test methods and evaluators to conduct In-Vivo clinical safety and efficacy testing of hair care range of products. A total of 40 subjects will be enrolled.
Status | Completed |
Enrollment | 40 |
Est. completion date | May 1, 2023 |
Est. primary completion date | May 1, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: 1. Age: 18 - 75 years (both inclusive) at the time of consent. 2. Sex: Males and non-pregnant/non-lactating females (preferably equal number of males and females). 3. Females of childbearing potential must have a self-reported negative urine pregnancy. 4. Subject is in good general health as determined by the Investigator on the basis of medical history. 5. Subject is willing and able to follow and allow study staff to performed study test methods 6. Subject is willing and able to follow the study directions, to participate in the study, returning for all specified visits. 7. Subject must be able to understand and provide written informed consent to participate in the study. Exclusion Criteria: 1. Subject have history of allergy to any ink. 2. Subject have participated any clinical research study related to hair care products. 3. Subject having history of diabetes 4. Subject have history of mastectomy for cancer involving removal of lymph nodes within the past year, or treatment of any type of cancer within the last 6 months. 5. Subject having known history of any skin diseases including eczema, atopic dermatitis or active cancer. |
Country | Name | City | State |
---|---|---|---|
India | NovoBliss Research Pvt Ltd | Gandhinagar | Gujarat |
Lead Sponsor | Collaborator |
---|---|
NovoBliss Research Pvt Ltd |
India,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluate the standardize the methods, procedural steps | Validate the hair growth rate measurement | Day 01 to Day 04 | |
Primary | Evaluate the standardize the methods, procedural steps | 60-s combing test | Day 01 to Day 04 | |
Primary | Evaluate the standardize the methods, procedural steps | Hair Pull test | Day 01 to Day 04 | |
Primary | Evaluate the standardize the methods, procedural steps | Hair Pluck test | Day 01 to Day 04 | |
Primary | Evaluate the standardize the methods, procedural steps | Subjective scoring of Hair quality appearance and scalp condition | Day 01 to Day 04 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02664883 -
Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer
|
||
Completed |
NCT05611281 -
GS3-007a Oral Solution in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03457480 -
Text Messages in Preventing Tobacco Use in Young Adults
|
N/A | |
Completed |
NCT05358756 -
A Study of Bioavailability and Food Effect of SACT-1 and Edurant® Tablets in Healthy Adult Volunteers
|
Phase 1 | |
Completed |
NCT06037395 -
Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects
|
Phase 1 | |
Active, not recruiting |
NCT04032106 -
HPV Vaccine Intervention for Young Sexual Minority Men
|
N/A | |
Completed |
NCT04062955 -
Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy Participants
|
N/A | |
Recruiting |
NCT03897270 -
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
|
N/A | |
Completed |
NCT01846520 -
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers
|
N/A | |
Completed |
NCT02960100 -
mHealth Intervention in Increasing HPV Vaccinations in College Students
|
N/A | |
Completed |
NCT03698318 -
Pharmacokinetics Assessing Bioavailability of Gingerols and Shogaols of Five Ginger Extracts
|
N/A | |
Completed |
NCT05497635 -
A Study of STSA-1002 in Healthy Subjects
|
Phase 1 | |
Active, not recruiting |
NCT03303846 -
Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients
|
N/A | |
Terminated |
NCT05559125 -
A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03584100 -
Effect of Pneumatic Tourniquet on Arm Swelling After Lymph Node Removal
|
N/A | |
Recruiting |
NCT05117385 -
The Effect of the Consumption of 4 Botanical Extracts on Immunity in Healthy Adults (B-4-Immune)
|
N/A | |
Active, not recruiting |
NCT05660720 -
Evaluate the Effect of Orelabrutinib on Cardiac Repolarization in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT03188848 -
Dose Escalating Study of BPI-3016 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01908920 -
Osteopathic Manipulative Treatment Effects on High Frequency Parameters in Healthy Subjects
|
N/A | |
Active, not recruiting |
NCT03491176 -
Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer
|
N/A |